Skip to main navigation Skip to search Skip to main content

Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRASG12D-mutated pancreatic cancer

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number79
JournalExperimental Hematology and Oncology
Volume14
Issue number1
DOIs
StatePublished - May 26 2025

ASJC Scopus Subject Areas

  • Hematology
  • Oncology
  • Cancer Research

Keywords

  • ATP
  • Bedaquiline
  • DDIT
  • Helicase
  • KRAS
  • MRTX1133
  • Mitochondrion
  • NFκB2
  • PDAC
  • S100P

Cite this